Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 4 1

Status

Not yet recruiting 2Completed 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 2Gynecologic 1Genitourinary 1

Conditions

Breast Neoplasms 2Squamous Intraepithelial Lesions 1Muscle Invasive Bladder Cancer (MIBC) 1Inflammation 1

Interventions

Specimen Handling 642pembrolizumab 565Magnetic Resonance Spectroscopy 548Carboplatin 426Cisplatin 377Cyclophosphamide 374Biopsy 365Paclitaxel 306Nivolumab 303Gemcitabine 303Radiotherapy 274Bevacizumab 240Dexamethasone 209fludarabine 207Docetaxel 191durvalumab 183atezolizumab 177Oxaliplatin 174venetoclax 168Fluorouracil 167Rituximab 166Pemetrexed 164Capecitabine 161Radiation 159Doxorubicin 159Radiosurgery 150Etoposide 137Ipilimumab 135Leucovorin 133Lenalidomide 132

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Probiotics × 90 days × Clear all
NCT07607548 2026-05-26

Assessment of the Effect of Probiotic Supplementation on Proinflammatory Mechanisms Induced by Systemic Treatment in Women With Breast Cancer

Poznan University of Medical Sciences

Phase NA Completed
60 enrolled
Breast

Breast Neoplasms, Inflammation

NCT06949800 2026-05-01

CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial

University of California, San Francisco

Phase 2 Not yet recruiting
90 enrolled
Gynecologic

Squamous Intraepithelial Lesions

NCT05562518 2026-04-30

GRACE

University Hospital, Ghent

Phase 4 Active not recruiting
160 enrolled
Breast

Breast Neoplasms

NCT07474064 2026-03-17

Probiotics Combined With Targeted Therapy Plus Immunotherapy in Bladder-Preserving Setting for Patients With MIBC

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Not yet recruiting
146 enrolled
Genitourinary

Muscle Invasive Bladder Cancer (MIBC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡